Corindus Vascular Robotics (NYSE:CVRS) moved to forestall a group of lawsuits brought over its pending $1.1 billion merger with Siemens Healthineers (NYSE:SI). Corindus announced August 9 that it was set to be acquired by Siemens in an all-cash deal for $4.28 per CVRS share. The announcement prompted six lawsuits alleging that Corindus provided incomplete and misleading financial projections […]
Siemens Healthineers
Siemens Healthineers absorbs healthcare consultancy ECG
ECG Management Consultants said this week that it was joining Siemens Healthineers as a stand-alone unit in an effort to improve healthcare delivery and enhance client relationships. Siemens Healthineers will acquire a majority stake in ECG, with the transaction expected to close in the fourth calendar quarter of 2019, subject to regulatory approvals. ECG said […]
The 10 largest medical device companies in the world
The merger of the French lens manufacturer Essilor with Italian eyewear maker Luxottica boosted the new EssilorLuxottica into the top 10 of the Big 100 list of largest medical device companies in the world — produced by our sister site Medical Design & Outsourcing. Overall, consolidation continues to play a major role in shaping the […]
Siemens Healthineers wins FDA nod for Artis Icono angiography line
Siemens Healthineers said yesterday that it won FDA clearance for its Artis Icono angiography systems for performing a wide range of minimally invasive procedures in a single interventional suite. The Artis Icono platform includes a biplane system engineered for neuroradiology and abdominal imaging, and a floor-mounted, single-plane system for vascular, interventional cardiology, surgical and oncology […]
FTC clears $1.1B Corindus buyout by Siemens Healthineers
Corindus Vascular Robotics (NYSE:CVRS) said today that the U.S. Federal Trade Commission granted early termination of the waiting period on its $1.1 billion acquisition by Siemens Healthineers (NYSE:SI). The all-cash deal for Waltham, Mass.-based Corindus, which is developing a robot-assisted device for vascular procedures, calls for the German conglomerate’s healthcare arm to pony up $4.28 per share. […]